Tyrosinimea

Reading File
Tyrosinemia is an inborn error of metabolism involving defective tyrosine catabolism. There are three types (Type I, II, III), with Type I being the most severe, causing progressive liver disease, renal tubular dysfunction (Fanconi syndrome), and painful neurologic crises. It is treated with NTBC (nitisinone) plus a low-phenylalanine/tyrosine diet.
Searching sources...
Finding Sources
Searching PubMed

tyrosinemia

Reading File
Reading File
Reading File
Reading File
Finding Sources
Here is a detailed overview of Tyrosinemia:

Tyrosinemia

Tyrosinemia refers to a group of inborn errors of metabolism caused by defective degradation of the amino acid tyrosine. There are three distinct types, each caused by a different enzymatic defect.

Tyrosine Degradation Pathway

Phenylalanine -> Tyrosine -> 4-hydroxyphenylpyruvate -> Homogentisate -> Maleylacetoacetate -> Fumarylacetoacetate -> Fumarate + Acetoacetate (via FAH)

Type I - Hepatorenal Tyrosinemia (Most Severe)

Enzyme Defect

Fumarylacetoacetate hydrolase (FAH) - the terminal enzyme in tyrosine catabolism. Gene: FAH (autosomal recessive).

Epidemiology

  • Incidence ~1:100,000 worldwide
  • Very high frequency in Saguenay-Lac Saint-Jean region of Quebec, Canada (1:1,800 due to founder effect)

Pathophysiology

  • Fumarylacetoacetate and maleylacetoacetate accumulate and are hepatotoxic
  • Succinylacetone accumulates - this is the pathognomonic marker
  • Succinylacetone inhibits delta-aminolevulinate dehydratase (ALA dehydratase), causing buildup of 5-aminolevulinic acid (ALA), producing porphyria-like neurologic crises

Clinical Features

Acute presentation (< 6 months):
  • Acute liver failure
  • Coagulopathy, hypoglycemia, hypoalbuminemia
  • Only mildly elevated transaminases (disproportionately low for degree of liver failure - a clue!)
  • Neonatal cholestasis
Chronic presentation (> 6 months):
  • Failure to thrive
  • Hepatomegaly, cirrhosis
  • Renal tubular dysfunction - Fanconi syndrome: glycosuria, proteinuria, aminoaciduria, hyperphosphaturia
  • Hypophosphatemic rickets
  • Very elevated alpha-fetoprotein (AFP) for age
Neurologic crises (porphyria-like):
  • Painful paresthesias
  • Autonomic dysfunction
  • Progressive paralysis and respiratory depression
  • Can be fatal
Cardiac:
  • Cardiomyopathy in ~30% of newly diagnosed patients (interventricular septal hypertrophy most common); typically resolves with treatment
Malignancy:
  • Very high risk for hepatocellular carcinoma (HCC) - can occur as young as 2 years of age in untreated patients

Liver Histology

  • Macrovesicular steatosis
  • Pseudoacinar rosette formation of hepatocytes (may contain bile plugs)
  • Hemosiderosis
  • Hepatocyte necrosis and apoptosis
  • Fine diffuse fibrosis progressing to micronodular cirrhosis
  • Regenerative nodules and HCC

Diagnosis

  1. Urine succinylacetone - pathognomonic; gold standard. Succinylacetone is NOT elevated in other causes of hypertyrosinemia
  2. Elevated plasma tyrosine (nonspecific - also elevated in TYR2, TYR3, liver disease, prematurity)
  3. Elevated AFP (markedly high)
  4. FAH enzyme activity in red blood cells (research labs)
  5. Newborn screening: succinylacetone is the primary marker (tyrosine alone is unreliable in the newborn period)

Treatment

  1. NTBC (nitisinone) - inhibitor of 4-hydroxyphenylpyruvate dioxygenase, the enzyme upstream of FAH. This blocks production of succinylacetone, which becomes undetectable in urine almost immediately. This is now first-line treatment.
  2. Dietary restriction of phenylalanine and tyrosine (precursors) - diet alone does not prevent liver decompensation or cirrhosis but benefits the kidneys
  3. Liver transplantation - indicated for patients progressing to liver failure despite NTBC, or for those who develop HCC. Reverses hepatic metabolic abnormalities and prevents neurologic disease.
  4. Monitoring: plasma amino acids (diet adequacy), serial AFP (HCC surveillance), urine succinylacetone (NTBC response)

Type II - Oculocutaneous Tyrosinemia (Richner-Hanhart Syndrome)

Enzyme Defect

Hepatic tyrosine aminotransferase (TAT) - the first step in tyrosine catabolism. Gene: TAT (autosomal recessive).

Clinical Features (triad)

  1. Ocular: Lacrimation, photophobia, corneal erosions, neovascularization, and opacification (from crystalline tyrosine deposits). Usually begins in the 1st-2nd year.
  2. Skin: Painful palmar and plantar hyperkeratosis on weight-bearing areas, tracking along dermatoglyphs; bullae possible. May not appear until the 2nd decade.
  3. Neurologic: Mild to moderate intellectual disability in >50% of patients; self-mutilation, language defects, incoordination

Key Point

  • Serum tyrosine is markedly elevated (>0.18 mM)
  • In any child with palmoplantar keratoderma + photophobia/tearing, think TYR2

Diagnosis

  • Elevated serum and urine tyrosine
  • No succinylacetone (distinguishes from TYR1)

Treatment

  • Low-tyrosine, low-phenylalanine diet (improves/prevents eye and skin lesions; may not reverse established intellectual disability)
  • Oral retinoids for skin lesions
  • Must be started early to prevent neurologic damage

Type III - Tyrosinemia (HPD Deficiency)

Enzyme Defect

4-Hydroxyphenylpyruvate dioxygenase (HPD). Gene: HPD (autosomal recessive).

Clinical Features

  • Rarest form
  • Primarily neurologic: intellectual disability, seizures, ataxia
  • Mild hypertyrosinemia
  • No liver or eye involvement

Summary Comparison Table

FeatureType I (TYR1)Type II (TYR2)Type III (TYR3)
Enzyme defectFAHTATHPD
GeneFAHTATHPD
Diagnostic markerSuccinylacetone (urine)Elevated serum tyrosineElevated serum tyrosine
Liver diseaseSevere (cirrhosis, HCC)NoneNone
Renal (Fanconi)YesNoNo
Eye findingsNoYes (corneal erosions)No
SkinNoYes (palmoplantar keratosis)No
NeurologyPorphyria-like crisesMild intellectual disabilityIntellectual disability, seizures
Key treatmentNTBC + diet ± liver TxLow-Tyr/Phe dietLow-Tyr/Phe diet

Key High-Yield Points

  • TYR1 causes disproportionately low transaminases for the degree of liver dysfunction - a classic exam point
  • Succinylacetone in urine = diagnostic for TYR1 (not elevated in other causes of hypertyrosinemia)
  • NTBC works by blocking upstream of the enzyme defect, preventing accumulation of toxic intermediates
  • HCC can occur at age 2 - regular AFP monitoring is mandatory in TYR1
  • Porphyria-like neurologic crises in TYR1 are due to ALA accumulation from succinylacetone-mediated inhibition of ALA dehydratase
Sources: Yamada's Textbook of Gastroenterology, 7th ed. | Tietz Textbook of Laboratory Medicine, 7th ed. | Adams and Victor's Principles of Neurology, 12th ed. | Andrews' Diseases of the Skin, Clinical Dermatology

Generate the pdf

Reading File
Running Command

ls /home/daytona/workspace/ 2>/dev/null || mkdir -p /home/daytona/workspace

Running Command

mkdir -p /home/daytona/workspace/tyrosinemia-pdf && cat > /home/daytona/workspace/tyrosinemia-pdf/generate.py << 'PYEOF' from reportlab.lib.pagesizes import A4 from reportlab.lib import colors from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.lib.units import cm, mm from reportlab.platypus import (SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, HRFlowable, KeepTogether) from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY from reportlab.platypus import PageBreak OUTPUT = "/home/daytona/workspace/tyrosinemia-pdf/Tyrosinemia.pdf" # ── Colour palette ────────────────────────────────────────────────────────── DARK_BLUE = colors.HexColor("#1a3a5c") MID_BLUE = colors.HexColor("#2e6da4") LIGHT_BLUE = colors.HexColor("#d6e8f7") ACCENT = colors.HexColor("#e8a020") TABLE_HEAD = colors.HexColor("#2e6da4") TABLE_ODD = colors.HexColor("#f0f7ff") TABLE_EVEN = colors.white TEXT_DARK = colors.HexColor("#1c1c1c") BORDER_CLR = colors.HexColor("#2e6da4") # ── Document ──────────────────────────────────────────────────────────────── doc = SimpleDocTemplate( OUTPUT, pagesize=A4, leftMargin=2*cm, rightMargin=2*cm, topMargin=2.5*cm, bottomMargin=2*cm, title="Tyrosinemia - Clinical Overview", author="Orris Medical" ) styles = getSampleStyleSheet() # Custom styles title_style = ParagraphStyle( "DocTitle", parent=styles["Normal"], fontSize=26, textColor=colors.white, fontName="Helvetica-Bold", alignment=TA_CENTER, spaceAfter=4 ) subtitle_style = ParagraphStyle( "DocSub", parent=styles["Normal"], fontSize=12, textColor=colors.HexColor("#c8e0f5"), fontName="Helvetica", alignment=TA_CENTER, spaceAfter=2 ) h1 = ParagraphStyle( "H1", parent=styles["Normal"], fontSize=14, textColor=colors.white, fontName="Helvetica-Bold", spaceBefore=14, spaceAfter=6, backColor=MID_BLUE, borderPad=(6, 4, 6, 8), leftIndent=-10, rightIndent=-10 ) h2 = ParagraphStyle( "H2", parent=styles["Normal"], fontSize=12, textColor=DARK_BLUE, fontName="Helvetica-Bold", spaceBefore=10, spaceAfter=4, borderPad=(0, 0, 2, 0), ) h3 = ParagraphStyle( "H3", parent=styles["Normal"], fontSize=10.5, textColor=MID_BLUE, fontName="Helvetica-Bold", spaceBefore=7, spaceAfter=3 ) body = ParagraphStyle( "Body", parent=styles["Normal"], fontSize=9.5, textColor=TEXT_DARK, fontName="Helvetica", leading=14, spaceAfter=4, alignment=TA_JUSTIFY ) bullet = ParagraphStyle( "Bullet", parent=styles["Normal"], fontSize=9.5, textColor=TEXT_DARK, fontName="Helvetica", leading=13, spaceAfter=2, leftIndent=14, bulletIndent=4 ) highlight_box = ParagraphStyle( "Highlight", parent=styles["Normal"], fontSize=9.5, textColor=DARK_BLUE, fontName="Helvetica-BoldOblique", leading=13, backColor=colors.HexColor("#fff8e1"), borderColor=ACCENT, borderWidth=1, borderPad=6, spaceAfter=6, spaceBefore=4 ) source_style = ParagraphStyle( "Source", parent=styles["Normal"], fontSize=7.5, textColor=colors.grey, fontName="Helvetica-Oblique", spaceAfter=2, leading=11 ) # ── Helper builders ────────────────────────────────────────────────────────── def hr(): return HRFlowable(width="100%", thickness=1, color=MID_BLUE, spaceAfter=6, spaceBefore=2) def section_header(text): # Blue pill header data = [[Paragraph(f" {text}", ParagraphStyle( "SH", parent=styles["Normal"], fontSize=13, textColor=colors.white, fontName="Helvetica-Bold", leading=16 ))]] t = Table(data, colWidths=[17*cm]) t.setStyle(TableStyle([ ("BACKGROUND", (0,0), (-1,-1), MID_BLUE), ("ROUNDEDCORNERS", [4]), ("TOPPADDING", (0,0), (-1,-1), 6), ("BOTTOMPADDING", (0,0), (-1,-1), 6), ("LEFTPADDING", (0,0), (-1,-1), 10), ])) return t def sub_header(text): return Paragraph(f"<b><font color='#{DARK_BLUE.hexval()[2:]}'>▸ {text}</font></b>", h2) def bullet_item(text): return Paragraph(f"• {text}", bullet) def build_table(headers, rows, col_widths=None): header_row = [Paragraph(f"<b>{h}</b>", ParagraphStyle( "TH", parent=styles["Normal"], fontSize=8.5, textColor=colors.white, fontName="Helvetica-Bold", alignment=TA_CENTER, leading=12 )) for h in headers] body_rows = [] for i, row in enumerate(rows): styled = [Paragraph(str(cell), ParagraphStyle( "TD", parent=styles["Normal"], fontSize=8.5, textColor=TEXT_DARK, fontName="Helvetica", leading=12, alignment=TA_CENTER )) for cell in row] body_rows.append(styled) all_rows = [header_row] + body_rows if col_widths is None: col_widths = [17*cm / len(headers)] * len(headers) t = Table(all_rows, colWidths=col_widths, repeatRows=1) style_cmds = [ ("BACKGROUND", (0,0), (-1,0), TABLE_HEAD), ("TEXTCOLOR", (0,0), (-1,0), colors.white), ("FONTNAME", (0,0), (-1,0), "Helvetica-Bold"), ("GRID", (0,0), (-1,-1), 0.4, colors.HexColor("#b0c8e0")), ("ROWBACKGROUNDS",(0,1), (-1,-1), [TABLE_ODD, TABLE_EVEN]), ("TOPPADDING", (0,0), (-1,-1), 5), ("BOTTOMPADDING", (0,0), (-1,-1), 5), ("LEFTPADDING", (0,0), (-1,-1), 6), ("VALIGN", (0,0), (-1,-1), "MIDDLE"), ] t.setStyle(TableStyle(style_cmds)) return t # ── Title Banner ───────────────────────────────────────────────────────────── def title_banner(): data = [[ Paragraph("TYROSINEMIA", title_style), Paragraph("Inborn Errors of Tyrosine Metabolism", subtitle_style), Paragraph("Clinical Overview | Orris Medical | 2026", ParagraphStyle( "BannerSub2", parent=styles["Normal"], fontSize=9, textColor=colors.HexColor("#a0c4e8"), fontName="Helvetica", alignment=TA_CENTER )) ]] # Transpose to rows inner = [ [Paragraph("TYROSINEMIA", title_style)], [Paragraph("Inborn Errors of Tyrosine Metabolism", subtitle_style)], [Paragraph("Clinical Overview | Orris Medical | July 2026", ParagraphStyle( "BS2", parent=styles["Normal"], fontSize=9, textColor=colors.HexColor("#a0c4e8"), fontName="Helvetica", alignment=TA_CENTER ))] ] t = Table(inner, colWidths=[17*cm]) t.setStyle(TableStyle([ ("BACKGROUND", (0,0), (-1,-1), DARK_BLUE), ("TOPPADDING", (0,0), (-1,-1), 8), ("BOTTOMPADDING", (0,0), (-1,-1), 8), ("LEFTPADDING", (0,0), (-1,-1), 10), ("RIGHTPADDING", (0,0), (-1,-1), 10), ])) return t # ══════════════════════════════════════════════════════════════════════════════ # BUILD STORY # ══════════════════════════════════════════════════════════════════════════════ story = [] # TITLE story.append(title_banner()) story.append(Spacer(1, 10)) # INTRO story.append(section_header("Overview")) story.append(Spacer(1, 6)) story.append(Paragraph( "Tyrosinemia is a group of <b>autosomal recessive inborn errors of metabolism</b> " "characterised by defective degradation of the amino acid <b>tyrosine</b>. Three distinct " "types exist, each caused by a different enzymatic defect along the tyrosine catabolism pathway. " "Type I is the most severe, with life-threatening liver disease, renal tubulopathy, and risk of " "hepatocellular carcinoma (HCC). Early diagnosis via newborn screening and treatment with " "<b>NTBC (nitisinone)</b> has transformed outcomes dramatically.", body)) story.append(Spacer(1, 4)) # PATHWAY BOX pathway_data = [ [Paragraph("<b>Tyrosine Catabolism Pathway</b>", ParagraphStyle( "PH", parent=styles["Normal"], fontSize=10, textColor=DARK_BLUE, fontName="Helvetica-Bold", alignment=TA_CENTER ))], [Paragraph( "Phenylalanine → <b>Tyrosine</b> → 4-Hydroxyphenylpyruvate (blocked in TYR III: HPD)<br/>" "→ Homogentisate → Maleylacetoacetate → Fumarylacetoacetate (blocked in TYR I: FAH)<br/>" "→ Fumarate + Acetoacetate<br/><br/>" "<i>Tyrosine aminotransferase (TAT) - first step; blocked in TYR II</i>", ParagraphStyle("PB", parent=styles["Normal"], fontSize=9, textColor=TEXT_DARK, fontName="Helvetica", leading=14, alignment=TA_CENTER) )] ] pt = Table(pathway_data, colWidths=[17*cm]) pt.setStyle(TableStyle([ ("BACKGROUND", (0,0), (-1,0), LIGHT_BLUE), ("BACKGROUND", (0,1), (-1,-1), colors.HexColor("#f5faff")), ("BOX", (0,0), (-1,-1), 1, BORDER_CLR), ("TOPPADDING", (0,0), (-1,-1), 7), ("BOTTOMPADDING", (0,0), (-1,-1), 7), ("LEFTPADDING", (0,0), (-1,-1), 12), ])) story.append(pt) story.append(Spacer(1, 10)) # ── TYPE I ────────────────────────────────────────────────────────────────── story.append(section_header("Type I - Hepatorenal Tyrosinemia (Most Severe)")) story.append(Spacer(1, 6)) story.append(sub_header("Enzyme Defect & Genetics")) story.append(bullet_item("<b>Enzyme:</b> Fumarylacetoacetate hydrolase (FAH) - terminal enzyme in tyrosine catabolism")) story.append(bullet_item("<b>Gene:</b> FAH | Inheritance: Autosomal recessive")) story.append(bullet_item("<b>Incidence:</b> ~1:100,000 worldwide; 1:1,800 in Saguenay-Lac Saint-Jean, Quebec (founder effect)")) story.append(Spacer(1, 4)) story.append(sub_header("Pathophysiology")) story.append(bullet_item("Fumarylacetoacetate and maleylacetoacetate accumulate and are <b>directly hepatotoxic</b>")) story.append(bullet_item("<b>Succinylacetone</b> accumulates - the pathognomonic marker of TYR1")) story.append(bullet_item("Succinylacetone inhibits <b>delta-aminolevulinate dehydratase (ALA dehydratase)</b>, causing buildup of 5-ALA and producing a <b>porphyria-like neurologic syndrome</b>")) story.append(bullet_item("Succinylacetone-induced Fanconi syndrome causes renal tubulopathy and hypophosphatemic rickets")) story.append(Spacer(1, 4)) story.append(sub_header("Clinical Features")) # Two-column layout for clinical features col1 = [ Paragraph("<b>Acute (< 6 months)</b>", h3), bullet_item("Acute liver failure"), bullet_item("Coagulopathy, hypoglycemia"), bullet_item("Hypoalbuminemia"), bullet_item("Neonatal cholestasis"), bullet_item("Mildly elevated transaminases (disproportionate to liver dysfunction - key clue!)"), Spacer(1, 6), Paragraph("<b>Neurologic Crises (Porphyria-like)</b>", h3), bullet_item("Painful paresthesias"), bullet_item("Autonomic dysfunction"), bullet_item("Progressive paralysis"), bullet_item("Respiratory depression (can be fatal)"), ] col2 = [ Paragraph("<b>Chronic (> 6 months)</b>", h3), bullet_item("Failure to thrive"), bullet_item("Hepatomegaly, cirrhosis"), bullet_item("Renal Fanconi syndrome: glycosuria, proteinuria, aminoaciduria, hyperphosphaturia"), bullet_item("Hypophosphatemic rickets"), bullet_item("Very elevated AFP for age"), Spacer(1, 6), Paragraph("<b>Cardiac</b>", h3), bullet_item("Cardiomyopathy in ~30% at diagnosis"), bullet_item("Interventricular septal hypertrophy (most common)"), bullet_item("Resolves with treatment in most cases"), ] clin_table = Table([[col1, col2]], colWidths=[8.3*cm, 8.3*cm]) clin_table.setStyle(TableStyle([ ("VALIGN", (0,0), (-1,-1), "TOP"), ("LEFTPADDING", (0,0), (-1,-1), 4), ("RIGHTPADDING", (0,0), (-1,-1), 4), ("LINEAFTER", (0,0), (0,-1), 0.5, colors.HexColor("#b0c8e0")), ])) story.append(clin_table) story.append(Spacer(1, 4)) story.append(sub_header("Hepatocellular Carcinoma Risk")) story.append(Paragraph( "<b>Very high risk for HCC</b> in untreated patients - can occur as early as <b>2 years of age</b>. " "All patients with TYR1 require regular AFP surveillance and imaging. " "HCC risk persists even with NTBC therapy (though markedly reduced).", body)) story.append(Spacer(1, 4)) story.append(sub_header("Liver Histology")) hist_items = [ "Macrovesicular steatosis", "Pseudoacinar rosette formation of hepatocytes (may contain bile plugs)", "Hemosiderosis", "Hepatocyte necrosis and apoptosis", "Fine diffuse fibrosis progressing to micronodular cirrhosis", "Regenerative nodules; frank HCC in advanced/untreated cases", ] for item in hist_items: story.append(bullet_item(item)) story.append(Spacer(1, 4)) story.append(sub_header("Diagnosis")) diag_data = [ ["Test", "Finding", "Notes"], ["Urine succinylacetone", "ELEVATED (pathognomonic)", "Gold standard; specific for TYR1"], ["Plasma tyrosine", "Elevated (nonspecific)", "Also elevated in TYR2, TYR3, liver disease, prematurity"], ["Serum AFP", "Markedly elevated for age", "Used for diagnosis and HCC monitoring"], ["FAH enzyme activity", "Deficient", "In red blood cells (research labs)"], ["Newborn screen", "Succinylacetone as primary marker", "Tyrosine alone is unreliable in neonates"], ["Urine organic acids", "Succinylacetone detected", "Routine metabolic workup"], ] story.append(build_table(diag_data[0], diag_data[1:], col_widths=[5*cm, 5.5*cm, 6.5*cm])) story.append(Spacer(1, 4)) story.append(sub_header("Treatment")) tx_items = [ ("<b>NTBC (nitisinone)</b>", "Inhibits 4-hydroxyphenylpyruvate dioxygenase (upstream of FAH). Blocks succinylacetone production - becomes undetectable in urine almost immediately. First-line therapy."), ("<b>Dietary restriction</b>", "Low phenylalanine and tyrosine diet. Does not prevent liver decompensation or cirrhosis alone, but benefits renal function. Monitored by plasma amino acids."), ("<b>Liver transplantation</b>", "Indicated for: (1) liver failure progressing despite NTBC, (2) development of HCC. Reverses hepatic abnormalities, prevents neurologic disease, stabilises renal disease."), ("<b>AFP monitoring</b>", "Serial AFP and liver imaging every 6 months for HCC surveillance, even on NTBC."), ] for title_tx, desc in tx_items: story.append(Paragraph(f"{title_tx}: {desc}", bullet)) story.append(Spacer(1, 4)) story.append(Paragraph( "HIGH-YIELD: NTBC works by blocking UPSTREAM of the enzyme defect, preventing synthesis " "of the toxic intermediates (fumarylacetoacetate, succinylacetone) rather than clearing them.", highlight_box)) # ── TYPE II ────────────────────────────────────────────────────────────────── story.append(Spacer(1, 6)) story.append(section_header("Type II - Oculocutaneous Tyrosinemia (Richner-Hanhart Syndrome)")) story.append(Spacer(1, 6)) story.append(sub_header("Enzyme Defect & Genetics")) story.append(bullet_item("<b>Enzyme:</b> Hepatic tyrosine aminotransferase (TAT) - first step of tyrosine catabolism")) story.append(bullet_item("<b>Gene:</b> TAT | Inheritance: Autosomal recessive")) story.append(Spacer(1, 4)) story.append(sub_header("Clinical Triad")) triad_data = [ ["System", "Features"], ["Ocular", "Lacrimation, photophobia, corneal erosions (crystalline tyrosine deposits)\nNeovascularization, corneal opacification. Onset 1st-2nd year."], ["Skin (Palmoplantar)", "Painful hyperkeratotic, erosive lesions on palms and soles\nWeight-bearing areas, tracks along dermatoglyphs; bullae possible"], ["Neurologic", "Mild-moderate intellectual disability in >50%\nSelf-mutilation, language defects, incoordination"], ] story.append(build_table(triad_data[0], triad_data[1:], col_widths=[4*cm, 13*cm])) story.append(Spacer(1, 4)) story.append(Paragraph( "CLINICAL PEARL: In any child with palmoplantar keratoderma + photophobia/tearing, " "consider Tyrosinemia Type II. Elevated serum tyrosine (>0.18 mM) confirms the diagnosis.", highlight_box)) story.append(sub_header("Diagnosis")) story.append(bullet_item("Markedly elevated serum and urine tyrosine")) story.append(bullet_item("No succinylacetone (distinguishes from TYR1)")) story.append(bullet_item("No liver disease")) story.append(Spacer(1, 4)) story.append(sub_header("Treatment")) story.append(bullet_item("Low-tyrosine, low-phenylalanine diet - improves/prevents eye and skin lesions")) story.append(bullet_item("Oral retinoids for skin lesions")) story.append(bullet_item("Must be started early - established intellectual disability may NOT reverse with diet")) story.append(Spacer(1, 6)) # ── TYPE III ────────────────────────────────────────────────────────────────── story.append(section_header("Type III - Tyrosinemia (HPD Deficiency)")) story.append(Spacer(1, 6)) story.append(sub_header("Enzyme Defect & Genetics")) story.append(bullet_item("<b>Enzyme:</b> 4-Hydroxyphenylpyruvate dioxygenase (HPD)")) story.append(bullet_item("<b>Gene:</b> HPD | Inheritance: Autosomal recessive")) story.append(bullet_item("Rarest of the three types")) story.append(Spacer(1, 4)) story.append(sub_header("Clinical Features")) story.append(bullet_item("Primarily neurologic: intellectual disability, seizures, ataxia")) story.append(bullet_item("Mild hypertyrosinemia")) story.append(bullet_item("NO liver involvement, NO eye involvement, NO renal involvement")) story.append(Spacer(1, 4)) story.append(sub_header("Treatment")) story.append(bullet_item("Low-tyrosine, low-phenylalanine diet")) story.append(Spacer(1, 10)) # ── COMPARISON TABLE ────────────────────────────────────────────────────────── story.append(section_header("Comparison of Tyrosinemia Types")) story.append(Spacer(1, 6)) comp_headers = ["Feature", "Type I (TYR1)", "Type II (TYR2)", "Type III (TYR3)"] comp_rows = [ ["Enzyme defect", "FAH", "TAT", "HPD"], ["Gene", "FAH", "TAT", "HPD"], ["Diagnostic marker", "Succinylacetone (urine)", "Elevated serum tyrosine", "Elevated serum tyrosine"], ["Liver disease", "Severe (cirrhosis, HCC)", "None", "None"], ["Renal (Fanconi)", "Yes", "No", "No"], ["Eye findings", "No", "Yes (corneal erosions)", "No"], ["Skin", "No", "Yes (palmoplantar keratosis)", "No"], ["Neurology", "Porphyria-like crises", "Mild intellectual disability", "ID, seizures, ataxia"], ["HCC risk", "Very high", "None", "None"], ["Key treatment", "NTBC + diet ± liver Tx", "Low-Tyr/Phe diet ± retinoids", "Low-Tyr/Phe diet"], ] # Custom widths for this table comp_widths = [4.2*cm, 4.3*cm, 4.3*cm, 4.3*cm] story.append(build_table(comp_headers, comp_rows, col_widths=comp_widths)) story.append(Spacer(1, 10)) # ── HIGH-YIELD SUMMARY ──────────────────────────────────────────────────────── story.append(section_header("High-Yield Exam Points")) story.append(Spacer(1, 6)) hye = [ ("Disproportionate liver dysfunction", "Transaminases are only mildly elevated despite severe liver failure in TYR1 - a classic exam clue"), ("Succinylacetone = diagnostic for TYR1", "Not elevated in any other cause of hypertyrosinemia; gold standard diagnostic test"), ("NTBC mechanism", "Blocks 4-HPD (upstream of FAH), preventing synthesis of toxic intermediates - succinylacetone disappears from urine almost immediately"), ("AFP monitoring", "Markedly elevated at diagnosis; serial monitoring mandatory for HCC surveillance even on NTBC"), ("Neurologic crisis mechanism", "Succinylacetone inhibits ALA dehydratase -> ALA accumulation -> porphyria-like presentation"), ("Quebec founder effect", "1:1,800 incidence in Saguenay-Lac Saint-Jean due to a single FAH mutation"), ("Newborn screening", "Succinylacetone is the primary NBS marker (tyrosine alone is unreliable in newborn period)"), ("Cardiomyopathy", "30% of TYR1 at diagnosis; resolves with NTBC treatment"), ("TYR2 triad", "Corneal erosions + palmoplantar keratoderma + intellectual disability = Richner-Hanhart syndrome"), ("Diet alone insufficient in TYR1", "Dietary restriction does not prevent liver decompensation or cirrhosis - NTBC is essential"), ] for i, (point, detail) in enumerate(hye): bg = TABLE_ODD if i % 2 == 0 else TABLE_EVEN row_data = [[ Paragraph(f"<b>{point}</b>", ParagraphStyle("HYH", parent=styles["Normal"], fontSize=9, textColor=DARK_BLUE, fontName="Helvetica-Bold", leading=12)), Paragraph(detail, ParagraphStyle("HYD", parent=styles["Normal"], fontSize=9, textColor=TEXT_DARK, fontName="Helvetica", leading=12)) ]] t = Table(row_data, colWidths=[5.5*cm, 11.5*cm]) t.setStyle(TableStyle([ ("BACKGROUND", (0,0), (-1,-1), bg), ("TOPPADDING", (0,0), (-1,-1), 5), ("BOTTOMPADDING",(0,0), (-1,-1), 5), ("LEFTPADDING", (0,0), (-1,-1), 8), ("GRID", (0,0), (-1,-1), 0.3, colors.HexColor("#b0c8e0")), ("VALIGN", (0,0), (-1,-1), "TOP"), ])) story.append(t) story.append(Spacer(1, 12)) # ── SOURCES ─────────────────────────────────────────────────────────────────── story.append(hr()) story.append(Paragraph("<b>Sources</b>", ParagraphStyle("SrcH", parent=styles["Normal"], fontSize=9, textColor=DARK_BLUE, fontName="Helvetica-Bold"))) sources = [ "Yamada's Textbook of Gastroenterology, 7th Edition", "Tietz Textbook of Laboratory Medicine, 7th Edition", "Adams and Victor's Principles of Neurology, 12th Edition", "Andrews' Diseases of the Skin - Clinical Dermatology", "Sleisenger and Fordtran's Gastrointestinal and Liver Disease", "Brenner and Rector's The Kidney, 2-Volume Set", ] for s in sources: story.append(Paragraph(f"• {s}", source_style)) story.append(Spacer(1, 6)) story.append(Paragraph("Generated by Orris Medical AI | July 2026 | For educational use only.", ParagraphStyle("Footer", parent=styles["Normal"], fontSize=7.5, textColor=colors.grey, fontName="Helvetica-Oblique", alignment=TA_CENTER))) # ── Build ───────────────────────────────────────────────────────────────────── doc.build(story) print(f"PDF generated: {OUTPUT}") PYEOF python3 /home/daytona/workspace/tyrosinemia-pdf/generate.py

Your PDF is ready! Here's the download link:

Tyrosinemia

PDF Document · PDF

The PDF includes:
  • Title banner with a professional blue header
  • Tyrosine catabolism pathway summary box
  • Type I (TYR1) - full coverage: pathophysiology, clinical features (acute/chronic), liver histology, diagnosis table, treatment
  • Type II (TYR2) - Richner-Hanhart syndrome triad table, diagnosis, treatment
  • Type III (TYR3) - enzyme defect and features
  • 3-type comparison table side by side
  • 10 high-yield exam points formatted for quick review
  • Source references from 6 authoritative textbooks
This is a shared conversation. Sign in to Orris to start your own chat.